Hypertension in response to chronic reductions in uterine perfusion in pregnant rats effect of tumor necrosis factor-α blockade

Hypertension

Volumn 52, Issue 6, 2008, Pages 1161-1167

  LaMarca, Babbette ^a   Speed, Josh ^a   Fournier, Lillian ^a   Babcock, Sara A ^a   Berry, Hunter ^a   Cockrell, Kathy ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Endothelial activation; Hypertension; Inflammation; Pregnancy

Indexed keywords

ENDOTHELIN 1; ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; ISCHEMIA; MATERNAL HYPERTENSION; NONHUMAN; ORGAN PERFUSION; PERFUSION PRESSURE; PLACENTA DISORDER; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; SPRAGUE DAWLEY RAT; UMBILICAL VEIN; UTERUS;

ANIMALS; BIRTH WEIGHT; BLOOD PRESSURE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; ISCHEMIA; KIDNEY; ORGAN SIZE; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; UTERUS;

EID: 57449107268     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.120881     Document Type: Article

References (29)

1. Minagawa M, Narita J, Tada T, Maruyama S, Shimizu T, Bannai M, Oya H, Hatakeyama K, Abo T. Mechanisms underlying immunologic States during pregnancy: possible association of the sympathetic nervous system. Cell Immunol. 1999;196:1-13.
2. Fisher SJ, Martin JM. Defects in placentation and placental perfusion. In: Lindheimer M, Roberts JM, and Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. II Ed. Stamford, CT: Appleton and Lange; 1998:377-394.
3. Ashworth JR, Baker PN, Warrend AY. Plasma from preeclamptic women induces a functional change in myometrial resisitance arteries. J Soc Gynecol Invest. 1997;4:71.
4. August P, Lindheimer MD. Pathophysiology of preeclampsia. Hypertension. 1995;142:2407-2426.
5. Roberts JM, Lain KY. Recent Insights into the pathogenesis of preeclampsia. Placenta. 2002;23:359-372.
6. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States. Am J Obstet Gynecol. 1990;163:460-465.
7. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by Villous expiants from the human placenta. J Clin Endocrinol Metab. 1997;82:1582-1588.
8. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immun. 1997;37:240-249.
9. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 1991;4:700-708.
10. Pober JS, Coltran RS. Cytokines and endothelial cell biology. Physiol Rev. 1990;70:427-451.
11. Granger JP, LaMarca BBD, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med. 2006;122:383-392.
12. LaMarca BD, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor alpha. Hypertension. 2005;46: 1022-1025.
13. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension. 2005;46:82-86.
14. Alexander BT, Rinewalt AN, Cockrell KL, Bennett WA, Granger JP. Endothelin-A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension. 2001; 37:485-489.
15. Roberts L, LaMarca B, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension. 2006;47: 615-618.
16. Mogolkoc R. etanerecept treatment in the endotoxin-induced uveitis of rats. Exp Eye Res. 2004;79:357-365.
17. Arenas AI, Armstrong SJ, Xu Y, Davidge ST. Chronic TNF-α inhibition enhances nitric oxide modulation of vascular function in estrogen deficient rats. Hypertension. 2005;46:76-81.
18. Kalarz B, Targonska-Stepniak B, Darmochwal-Kolarz C, Majdan M. Autoimmune aspects of treatment with TNF-alpha inhibitors. Postepy Hig Med Dosw. 2007;28:478-484.
19. Agirbasli M, Inane N, Byakan OA, Direskeneli H. The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders. Clin Exp Rheumatol. 2006;24: 580-583.
20. Hamilton K, Clair EW. Tumor necrosis factor-α blockade: a new era for effective management of rheumatoid arthritis. Expert Opin Pharmacother. 2000;1:1041-1052.
21. Fichtlscherer S, Rossig L, Breuere S, Vasa M, Dimmeler S, Zeiher AM. Tumor necrosis factor antagonism with etanerecept improves systemic endothelal vasoreactivity in patients with advanced heart failure. Circulation. 2001;25:3023-3025.
22. Granger JP. Inflammatory cytokines, vascular function, and hypertension. Am J Regul Intgr Comp Physiol. 2004;286:R989-R990.
23. Wang P, Ba ZF, Chaudry IH. Administration of TNF alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol. 1994;266: H2535-H2541.
24. Togashi N, Ura N, Higashiura K, Murakami H, Shimamoto K. Effect of TNF-alpha-converting enzyme inhibitor on insulin resistance in fructose-fed rats. Hypertension. 2002;39:578-580.
25. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002;283:R29-R45.
26. LaMarca BD, Ryan MJ, Granger JP. Pathophysiology of hypertension during preeclampsia: role of inflammatory cytokines. Curr Hypertens Rev. 2007;3:1.
27. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol. 1992;262:C854-C861.
28. Taylor RN, Varma M, Teng NN, Roberts JM. Women with preeclampsia have higher plasma endothelin levels man women with normal pregnancies. J Clin Endocrinol Metab. 1990;71:1675-1677.
29. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-alpha inhibition reduces renal inflammation in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2008;294: R76-R83.